HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Veterinary Medicine / Faculty of Veterinary Medicine >
Peer-reviewed Journal Articles, etc >

Treatment combining X-irradiation and a ribonucleoside anticancer drug, TAS106, effectively suppresses the growth of tumor cells transplanted in mice.

Files in This Item:
IJRO68-1.pdf823.71 kBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/26187

Title: Treatment combining X-irradiation and a ribonucleoside anticancer drug, TAS106, effectively suppresses the growth of tumor cells transplanted in mice.
Authors: Yasui, Hironobu Browse this author →KAKEN DB
Inanami, Osamu Browse this author →KAKEN DB
Asanuma, Taketoshi Browse this author
Iizuka, Daisuke Browse this author
Nakajima, Takayuki Browse this author
Kon, Yasuhiro Browse this author →KAKEN DB
Matsuda, Akira Browse this author →KAKEN DB
Kuwabara, Mikinori Browse this author
Keywords: Transplanted tumor
Anticancer drug
X-irradiation
Survivin
Issue Date: 1-May-2007
Publisher: Elsevier Inc.
Journal Title: International Journal of Radiation OncologyBiologyPhysics
Volume: 68
Issue: 1
Start Page: 218
End Page: 228
Publisher DOI: 10.1016/j.ijrobp.2006.12.061
PMID: 17448876
Abstract: Purpose: To examine the in vivo antitumor efficacy of X-irradiation combined with administration of a ribonucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106, ECyd), to tumor cell–transplanted mice. Methods and Materials: Colon26 murine rectum adenocarcinoma cells and MKN45 human gastric adenocarcinoma cells were inoculated into the footpad in BALB/c mice and severe combined immunodeficient mice, respectively. They were treated with a relatively low dose of X-irradiation (2 Gy) and low amounts of TAS106 (0.1 mg/kg and 0.5 mg/kg). The tumor growth was monitored by measuring the tumor volume from Day 5 to Day 16 for Colon26 and from Day 7 to Day 20 for MKN45. Histologic analyses for proliferative and apoptotic cells in the tumors were performed using Ki-67 immunohistochemical and terminal deoxynucleotidyl transferase-mediated nick end labeling staining. The expression of survivin, a key molecule related to tumor survival, was assessed by quantitative polymerase chain reaction and immunohistochemical analysis. Results: When X-irradiation and TAS106 treatment were combined, significant inhibition of tumor growth was observed in both types of tumors compared with mice treated with X-irradiation or TAS106 alone. Marked inhibition of tumor growth was observed in half of the mice that received the combined treatment three times at 2-day intervals. Parallel to these phenomena, the suppression of survivin expression and appearance of Ki-67–negative and apoptotic cells were observed. Conclusions: X-irradiation and TAS106 effectively suppress tumor growth in mice. The inhibition of survivin expression by TAS106 is thought to mainly contribute to the suppression of the tumor growth.
Relation: http://www.sciencedirect.com/science/journal/03603016
Type: article (author version)
URI: http://hdl.handle.net/2115/26187
Appears in Collections:獣医学院・獣医学研究院 (Graduate School of Veterinary Medicine / Faculty of Veterinary Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 稲波 修

Export metadata:

OAI-PMH ( junii2 , jpcoar )

MathJax is now OFF:


 

Feedback - Hokkaido University